Press Room
For media inquiries, contact
media@ivimhealth.com
Our Expert Opinion
Surprising Weight Loss Hacks Doctors Swear By to Melt Pounds
“People treat [sleep] like the clinical lever it actually is,” says Dr. Duncan. “I won’t even consider taking a patient off GLP-1 medications if they haven’t fixed their sleep first. It’s that fundamental.”
Read More
Are We Prescribing GLP-1s Wrong?
“GLP-1 medications changed what’s possible in obesity treatment. Our study proves such systems can be built, scaled, and produce results exceeding clinical trial outcomes.”
Read More
It’s About to Be Hot Peptide Summer
“There’s such a broad range of peptides available that you could argue that almost everybody could look at the options and possibly find one that could benefit them.”
Read More
Press Releases & Company Announcements
Ivím Health Welcomes FDA’s Long-Overdue Step Toward Regulated Peptide Access
Read MoreNew Peer-Reviewed Research Shows Comprehensive Care Model Drives Superior GLP-1 Outcomes
Read MoreIvím Health Unveils GLP-1 ID — Precision Dosing Meets Individualized Care
Read MoreOur Research
Real-world Outcomes of a comprehensive virtual GLP-1 care model in adults with obesity
Patients enrolled in the comprehensive care model achieved significantly greater weight reduction at 6 months compared to standard prescribing.
Adherence, dose individualization, and weight outcomes in compounded semaglutide therapy
Individualized titration protocols correlated with improved adherence and reduced GI adverse events.
Working on a story?
Our clinicians are available for expert commentary on GLP-1 therapy, peptide medicine, obesity care, and metabolic health policy.
